Artal Group’s ADC Therapeutics ADCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,018,461
Closed -$3.22M 4
2024
Q2
$3.22M Buy
+1,018,461
New +$3.22M 0.08% 66
2021
Q1
Sell
-95,000
Closed -$3.04M 138
2020
Q4
$3.04M Hold
95,000
0.07% 109
2020
Q3
$3.13M Sell
95,000
-41,000
-30% -$1.35M 0.08% 100
2020
Q2
$6.37M Buy
+136,000
New +$6.37M 0.18% 80